The 2022-2026 contract continues a 20 year-long relationship with the Government of Canada for pandemic and seasonal influenza vaccines Up to 80 million doses of pandemic influenza vaccine to be supplied to… Read More
Orion to receive an upfront payment of USD 290 million Agreement strengthens and complements Merck’s oncology pipeline RAHWAY, N.J.– Merck (NYSE: MRK), known as MSD outside the United States and… Read More
by Erin Brown-John Researchers are a step closer to understanding how Parkinson’s disease develops and progresses thanks to chemical biological tools developed at Simon Fraser University. New research, published this week in the Proceedings… Read More
VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on… Read More
In the medical device industry, scientific disciplines and engineering merge in the creation of innovations that benefit the health care system as well as society at large. Firms in this… Read More
